KR830002502A - 악성 종양의 진단 검사방법 - Google Patents

악성 종양의 진단 검사방법 Download PDF

Info

Publication number
KR830002502A
KR830002502A KR1019800001518A KR800001518A KR830002502A KR 830002502 A KR830002502 A KR 830002502A KR 1019800001518 A KR1019800001518 A KR 1019800001518A KR 800001518 A KR800001518 A KR 800001518A KR 830002502 A KR830002502 A KR 830002502A
Authority
KR
South Korea
Prior art keywords
cancer
inhibitory protein
bleomycin
determination
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019800001518A
Other languages
English (en)
Korean (ko)
Inventor
티. 크루크 스탠리
갈반 루이스
Original Assignee
알푸스 오. 죤슨
배일러칼리지 어넌 메디슨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알푸스 오. 죤슨, 배일러칼리지 어넌 메디슨 filed Critical 알푸스 오. 죤슨
Publication of KR830002502A publication Critical patent/KR830002502A/ko
Ceased legal-status Critical Current

Links

Classifications

    • G01N33/5755
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G01N33/57585
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • G01N2333/4704Inhibitors; Supressors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/50Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
KR1019800001518A 1979-04-10 1980-04-10 악성 종양의 진단 검사방법 Ceased KR830002502A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10
US28732 1979-04-10

Publications (1)

Publication Number Publication Date
KR830002502A true KR830002502A (ko) 1983-05-30

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800001518A Ceased KR830002502A (ko) 1979-04-10 1980-04-10 악성 종양의 진단 검사방법

Country Status (24)

Country Link
JP (1) JPS55143441A (OSRAM)
KR (1) KR830002502A (OSRAM)
AR (1) AR222700A1 (OSRAM)
AT (1) AT365343B (OSRAM)
AU (1) AU536522B2 (OSRAM)
BE (1) BE882669A (OSRAM)
CH (1) CH644453A5 (OSRAM)
DE (1) DE3013837A1 (OSRAM)
DK (1) DK149980A (OSRAM)
ES (1) ES8103380A1 (OSRAM)
FI (1) FI801078A7 (OSRAM)
FR (1) FR2454099A1 (OSRAM)
GB (1) GB2047712B (OSRAM)
GR (1) GR67692B (OSRAM)
HU (1) HU183122B (OSRAM)
IE (1) IE49981B1 (OSRAM)
IL (1) IL59772A (OSRAM)
IT (1) IT1143135B (OSRAM)
LU (1) LU82345A1 (OSRAM)
NL (1) NL8002094A (OSRAM)
NO (1) NO801018L (OSRAM)
PH (1) PH15637A (OSRAM)
SE (1) SE8002602L (OSRAM)
ZA (1) ZA802141B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
FR2454099B1 (OSRAM) 1984-01-27
NO801018L (no) 1980-10-13
IE800693L (en) 1980-10-10
LU82345A1 (fr) 1980-12-16
IE49981B1 (en) 1986-01-22
DK149980A (da) 1980-10-11
JPS55143441A (en) 1980-11-08
IT8048370A0 (it) 1980-04-09
ES490396A0 (es) 1981-02-16
GB2047712B (en) 1983-02-23
GR67692B (OSRAM) 1981-09-07
GB2047712A (en) 1980-12-03
AR222700A1 (es) 1981-06-15
NL8002094A (nl) 1980-10-14
AU5719380A (en) 1980-10-16
DE3013837A1 (de) 1980-10-30
ZA802141B (en) 1981-04-29
IT1143135B (it) 1986-10-22
FR2454099A1 (fr) 1980-11-07
AT365343B (de) 1982-01-11
IL59772A (en) 1983-05-15
ES8103380A1 (es) 1981-02-16
IL59772A0 (en) 1980-06-30
AU536522B2 (en) 1984-05-10
HU183122B (en) 1984-04-28
SE8002602L (sv) 1980-12-09
CH644453A5 (fr) 1984-07-31
PH15637A (en) 1983-03-11
ATA195780A (de) 1981-05-15
FI801078A7 (fi) 1981-01-01
BE882669A (fr) 1980-10-06

Similar Documents

Publication Publication Date Title
牧村進 et al. Quantitative determination of bovine serum Haptoglobin and its elevation in some inflammatory diseases.
Biewenga et al. Lactate dehydrogenase isoenzyme (s) linked to IgA immunoglobulin in a patient with a myocardial infarction
Ogawa et al. Dynein 2. A new adenosine triphosphatase from sea urchin sperm flagella.
BG45700A3 (bg) Метод за получаване на алфа-хетероциклично заместени толунитрили
Olsson et al. Gamma globulins of CSF and serum in multiple sclerosis: isoelectric focusing on polyacrylamide gel and agar gel electrophoresis
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
Searcy et al. A study of the specificity of the Berthelot colour reaction
BUTT et al. Plasma protein in hepatic disease: A study of the colloid osmotic pressure of blood serum and of ascitic fluid in various diseases of the liver
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
Wen et al. A non-isotopic method for the detection of telomerase activity in tumour tissues: TRAP-silver staining assay
Titus et al. Plasma aminopeptidase activity (oxytocinase) in pregnancy and labor
Dunlap et al. Interconversion of the multiple forms of dihydrofolate reductase from amethopterin-resistant Lactobacillus casei
ATE38521T1 (de) Neues protein (pp13), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
KR830002502A (ko) 악성 종양의 진단 검사방법
Kochiyama et al. Studies on a blue-green serum pigment of eel-I. Isolation and some physico-chemical properties
Haldar et al. Serological profiles in Indian post kala-azar dermal leishmaniasis
Omoto et al. The distribution of the group-specific component (Gc) subtypes in Japanese
Seltzer et al. Serum and tissue magnesium levels in human breast carcinoma
Kobayashi et al. Microheterogeneity of alpha and beta subunit of tubulin from microtubules of starfish (Asterias amurensis) sperm flagella
Yatzidis et al. An improved method for the simple and accurate colorimetric determination of urea with Ehrlich's reagent
Brackexridge The tyrosine and tryptophan content of blood serum in malignant disease
Queen et al. Haptoglobin type determination using non-carcinogenic reagents results on 192 normal subjects in maryland
Kishi et al. Isoelectric analysis of B gene-associated α-galactosyltransferases in human serum and saliva
Heilpern et al. Effect of disodium cromoglycate (Intal) on sputum protein composition
Mager et al. The use of cellulose acetate for the electrophoretic separation and quantitation of serum lactic dehydrogenase isozymes in normal and pathologic states

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19800410

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19840416

Patent event code: PE09021S01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19841226

Patent event code: PE09021S01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19850513

Patent event code: PE09021S01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19851111

Patent event code: PE09021S01D

PE0601 Decision on rejection of patent

Patent event date: 19860331

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19851111

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 19850513

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 19841226

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 19840416

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

PJ2001 Appeal

Appeal kind category: Appeal against decision to decline refusal

Decision date: 19870423

Appeal identifier: 1986201000259

Request date: 19860430

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19870522

Patent event code: PE09021S01D